COMMUNIQUÉS West-GlobeNewswire

Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025
30/04/2025
REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today [...]
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
30/04/2025
SAN ANTONIO, April 30, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO”), today provided strategic, [...]
Teladoc Health Reports First Quarter 2025 Results
30/04/2025
PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 (“First Quarter 2025”). [...]
CooperCompanies Appoints Barbara Carbone to Board of Directors
30/04/2025
SAN RAMON, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Barbara Carbone as an independent [...]
Best CBD Gummies of 2025: Cornbread Hemp CBD Products Help with Sleep, Pain, and Stress Relief
30/04/2025
Award-winning CBD gummies for sleep, stress, and sleep with organic full-spectrum formulations in flavors like berry, watermelon, strawberry, and blood orange. Louisville, KY, April 30, 2025 (GLOBE NEWSWIRE) -- In a [...]
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
30/04/2025
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free [...]
LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025
30/04/2025
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the [...]
New Study Shows Castle Biosciences’ DecisionDx®-Melanoma Test Outperforms Staging and CP-GEP in Identifying Patients at Low Risk of Sentinel Lymph Node Positivity
30/04/2025
Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to forgo sentinel lymph [...]
Ultragenyx to Host Conference Call for First Quarter 2025 Financial Results and Corporate Update
30/04/2025
NOVATO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra [...]
AdCare Hospital Names New Executive Director to Tackle Growing Addiction Crisis Across Massachusetts
30/04/2025
WORCESTER, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- As Massachusetts continues to see waves of preventable deaths from the opioid overdose epidemic, AdCare Hospital, a longstanding provider of addiction treatment [...]
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
01/05/2025
Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on April 24, 2025 [...]
UPDATE – The International Myeloma Foundation Mourns the Loss of Board Member and Longtime Philanthropist John O’Dwyer
01/05/2025
STUDIO CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime philanthropist John O’ [...]
EssilorLuxottica: Assemblée générale 2025 d’EssilorLuxottica
30/04/2025
Assemblée générale 2025 d’EssilorLuxottica Toutes les résolutions proposées par le Conseil d’administration adoptées Dividende de 3,95 € par action, avec possibilité de choisir un versement en actions Paris, France (30 [...]
EssilorLuxottica: EssilorLuxottica 2025 Annual Shareholders’ Meeting
30/04/2025
EssilorLuxottica 2025 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adopted Dividend of Euro 3.95 per share, with option for payment in shares Paris, France (30 April 2025 – 6:00 pm [...]
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
30/04/2025
Information relating to the holding of the Combined Shareholders’ Meeting of 21 May 2025 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting PARIS, FRANCE, 30 April 2025 - [...]
Interim Report Q1 2025: Growth challenged by market uncertainty – proactive cost mitigation initiated to support long-term margins
30/04/2025
Highlights The Hearing division delivered -1% organic revenue growth driven by a strong initial uptake of ReSound Vivia, but off-set by a challenged U.S. market as well as some slowdown of existing products in [...]
Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2025
30/04/2025
Assemblée Générale Annuelle du 30 avril 2025 Approbation des comptes sociaux et des comptes consolidés de l’exercice 2024 Distribution d’un dividende en numéraire de 3,92 euros par action, dont la mise en paiement [...]
Press Release: Annual General Meeting of April 30, 2025
30/04/2025
Annual General Meeting of April 30, 2025 Approval of the financial statements for the fiscal year 2024 Distribution of a cash dividend of €3.92 per share, with payment as of May 14, 2025 Board composition: renewal of [...]
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
30/04/2025
CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]

Pages